Affiliations of authors: L. Lipworth, International Epidemiology Institute, Rockville, MD, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN; L. R. Bailey, Program in Human Genetics, Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine; D. Trichopoulos, Department of Epidemiology, Harvard School of Public Health, Boston, MA
Correspondence to: Loren Lipworth, Sc.D., International Epidemiology Institute, 1455 Research Blvd., Suite 550, Rockville, MD 20850 (e-mail: loren3{at}earthlink.net).
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
More recently, the issue has undergone increasing scrutiny, and the attitude of the scientific community toward breast-feeding in relation to breast cancer has changed. A number of epidemiologic investigations have once again suggested that breast-feeding, particularly for extended periods of time, may be associated with a decreased risk of breast cancer, even after adjusting for potential confounders, and that this protection may be greatest among women under 50 years of age. It is difficult to summarize the magnitude of the association, if any, because of the variety of methodologies for reporting breast-feeding history; some studies report the effect of mean duration of breast-feeding for each child, others report the effect of cumulative duration following all births, and still others use different exposure measures.
The purpose of this review is to critically evaluate the existing epidemiologic evidence that history of breast-feeding may decrease the risk of breast cancer. Breast-feeding, if, in fact, it is shown to be protective against the development of breast cancer, is a potentially modifiable behavior and thus may represent one of the few opportunities for intervention at present.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
|
|
|
|
![]() |
EPIDEMIOLOGIC FINDINGS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Any History of Breast-Feeding
One measure of breast-feeding history that has been commonly used in
epidemiologic studies is that of "ever versus never"
breast-feeding. Overall, the evidence of an inverse association between
ever breast-feeding and breast cancer risk remains limited and
inconclusive, with results suggesting either no association or a
definite, although modest, protective effect. Among studies
(6-19) that have found a protective effect, reported RRs
among parous women who have ever breast-fed compared with women who
have never breast-fed range from 0.54 to just below 1.0 (Tables 1, 3
,
and 5
). However, a history of ever breast-feeding may be too crude an
indicator, and it may be more important to demonstrate a dose-response
association with increasing duration of breast-feeding in making causal
inferences.
Number of Children Breast-Fed
Recent studies have raised the question of whether the total number
of children that a woman has breast-fed may be etiologically relevant
or whether breast-feeding additional children after the first may
provide incremental protection against breast cancer development. Two
investigations (12,20) have reported that the more children a
woman breast-fed over the course of her lifetime, the lower her breast
cancer risk. Romieu et al. (12) found that, after adjustment
for several other risk factors, women who breast-fed four or more
children had a statistically significant 60% reduction in breast
cancer risk (odds ratio [OR] = 0.39; 95% confidence interval
[CI]
= 0.21-0.70) compared with women who never breast-fed; women who
breast-fed one or two children had an intermediate 43% reduction in
breast cancer risk (Table 3). However, a number of studies
(7,9,21,22) have found no such trend of decreasing risk with
increasing number of breast-fed children.
Cumulative Duration of Breast-Feeding
In many studies to date, the summation of all breast-feeding episodes is calculated as the total duration of breast-feeding for each woman, taking into account breast-feeding after all births. Using the cumulative duration as a measure of a woman's complete breast-feeding history allows for the examination of dose-response trends in drawing causal inferences. However, study populations have been drawn from different geographic areas and cultures, which could have important consequences with respect to the interpretation and comparison of findings from different studies. For instance, the classification of long-term breast-feeding ranged from 24 months or longer in several studies in Europe and in North America (5,6,8,10,11,14,20,21,23,24) to 100 months or longer in studies conducted in Asia and in other non-Western societies (25-28). Such diversity in the definition of exposure and nonexposure may account for the large discrepancies in the percentages of control women with extensive durations of breast-feeding. As a result, the magnitude of risk estimates could be greatly affected, and direct comparison of findings from different studies is difficult.
Among case-control studies that have found a decreasing trend in breast cancer risk with
increasing duration of breast-feeding among parous women, adjusted ORs for premenopausal
women who have breast-fed for at least 12 months range from 0.21 to slightly below 1.0
compared with parous women who never breast-fed (8,12,23,25-27,29)
(Tables 1-4). In the Cancer and Steroid Hormone Study, breast-feeding for 25 months or longer
was associated with an OR of 0.67 (23) (Table 3
).
Several studies (4-6,10,11,21,24,28) have failed to confirm an
inverse association between increasing total duration of breast-feeding and breast cancer risk in
parous women. Michels et al. (6), through a retrospective assessment of
breast-feeding in almost 90 000 parous women in the Nurse's Health Study,
reported that, in comparison to never breast-feeding, the RR was 0.86 for fewer than 3 months of
breast-feeding, 1.02 for 406 months, 0.95 for 7-11 months, 0.86 for 12-23 months, and 1.11 for
24 months or longer (Table 5). The only prospective study (4) of breast-feeding to date found no association among either premenopausal or
postmenopausal Norwegian women (Table 5
), despite the fact that it
included a high percentage of women with long durations of breast-feeding compared with
studies in other Western populations.
The failure to detect an association in some studies may be due to the low prevalence of
prolonged breast-feeding; for instance, only 17% of the women in the Nurses'
Health Study population breast-fed for at least 12 months (6). Thus, it is
difficult in Western studies to evaluate the influence of the extensive durations of breast-feeding
experienced by the majority of parous women in many non-Western populations. For example, in
China, where more than half of the women breast-feed for at least 3 years, a 64%
reduction in risk has been found among mainly premenopausal women who breast-fed for at least
10 years compared with women who never breast-fed (26).
Breast-feeding for 3-5 years was associated with little decrease in risk. In this study, more than
15% of the parous control subjects had breast-fed for more than 6 years. Similarly, Yuan
et al. (27) reported adjusted ORs of 0.35 and 0.37 after 73-108 months
and greater than 109 total months of breast-feeding, respectively, among Chinese women (Table
3). Another large study (25) conducted in 10
countries, the majority of which are non-Western societies, also found a statistically significant
reduction in breast cancer risk (OR = 0.72) among women with a prolonged duration
(73-107 months) of breast-feeding (Table 1
). Although it is difficult to
speculate at this stage that long-term breast-feeding has substantial incremental benefit in all
populations, there appears to be evidence for a protective influence on breast cancer risk among
women in non-Western societies with extensive cumulative durations of breast-feeding.
However, the potential for confounding by numerous factors, including low body weight and
height, low socioeconomic status, poor nutritional status and possibly associated amenorrhea, or
age at any pregnancy (30), cannot be ruled out.
Average Duration of Breast-Feeding Per Child
Average months of breast-feeding per child has been used as a
measure of breast-feeding history in a number of studies, based on the
hypothesis that a higher average duration of breast-feeding per child
may confer greater protection against breast cancer. However, four
studies (4,7,10,25) have failed to show any significant
association between breast cancer risk and this measure of
breast-feeding, while only one study (15) reported a
statistically significant trend of decreasing risk with increasing
average length of breast-feeding per child (Table 4).
Reasons for Cessation of Breast-Feeding
It has been hypothesized that the apparently protective effect of breast-feeding against breast cancer may be due to an elevated risk among women who either have difficulties in starting breast-feeding or who discontinue breast-feeding after a short interval (13), perhaps as a result of abnormalities in estrogen levels or other endocrine or psychosocial factors. A common reason for stopping breast-feeding, particularly among women who cease within the first month, is "insufficient milk supply," while breast infections, cracked nipples, and nonmedical circumstances such as returning to work are among other reasons given (13,15).
Byers et al. (13) reported a twofold increase in risk of breast cancer among premenopausal women who cited insufficient milk as the reason for having stopped breast-feeding compared with women who cited all other reasons combined. While adjusting for insufficient milk eliminated the increased risk observed among women in the category of shortest cumulative breast-feeding duration, it did not markedly reduce the overall strength of the inverse association between breast-feeding duration and breast cancer. These findings suggest that there may still be a protective effect of breast-feeding independent of those factors that lead women to cease breast-feeding because of a perception of insufficient milk (13). A population-based, case-control study conducted in British Columbia (14) reported significantly elevated risks of breast cancer among premenopausal women who tried to breast-feed for more than 1 month but were unsuccessful because of either "insufficient milk" (OR = 3.1) or other reasons (OR = 3.0) compared with women who breast-fed for at least 2 months. In both studies (13,14), the association between breast cancer and "insufficient milk" was less pronounced among postmenopausal women. In a number of other studies (10,11,15,17), however, there was no evidence that women who reported stopping breast-feeding because of a perception of insufficient milk were at markedly elevated risk of breast cancer.
It has also been suggested that breast cancer risk may be increased among women who do not breast-feed as a result of exposure to lactation suppressants. In a number of studies (11,15), a substantial proportion of women, often as many as 44%, reported having been given treatment to induce cessation of lactation after one or more births. However, the use of hormonal medication to suppress breast-feeding has not been consistently linked with an increased risk of breast cancer, either before or after adjustment for duration of breast-feeding (11,14,15,17,20,22,25).
Estrogen Receptor Status
Breast tumors that are estrogen receptor (ER) positive have been shown to be slower growing tumors, and patients with these types of tumors have fewer recurrences, longer survival, and seem to respond better to therapy than patients with ER-negative tumors (31). It has been suggested that the risk factor profiles for these breast tumor subtypes may differ, but there are limited data with respect to whether the ER status (ER positive versus ER negative) of breast tumors, as well as the actual concentration of ER protein, varies according to breast-feeding history. In an intracase analysis among parous women (32), those with ER-positive breast tumors were more likely than ER-negative cases to have breast-fed at least one child, although the results were of borderline significance. After adjustment for several known breast cancer risk factors, women who ever breast-fed were three times more likely than those who never breast-fed to have an ER-positive tumor as opposed to an ER-negative tumor (OR = 3.4; 95% CI = 1.3-8.7); similarly, a history of ever having breast-fed was significantly associated with the ER concentration of the tumor. In their case-control analysis, Hildreth et al. (32) showed that a history of ever having breast-fed was not associated with an increased risk for ER-positive breast tumors, while the association with ER-negative tumors was, if anything, inverse.
Another case-control study (33), which compared risk factors for ER-rich and ER-poor breast cancers, reported an inverse association between cumulative duration of breast-feeding and both ER-positive and ER-negative tumors. In particular, women who breast-fed for longer than 13 cumulative months had a decreased OR of 0.43 (95% CI = 0.20-0.95) for ER-positive breast cancer and 0.71 (95% CI = 0.31-1.6) for ER-negative breast cancer. To date, a plausible biologic mechanism for differential influences of breast-feeding on the ER status of a tumor has not been put forth, and the findings should be interpreted with caution until they are confirmed in other studies.
Ethnic Differences
There is striking geographic variation in breast cancer incidence rates, with the highest rates seen in North America and in Europe and the lowest rates in Asia and in Africa. While a number of studies (7,25-28) have evaluated breast cancer risk factors, including breast-feeding, among Asian and African populations, the epidemiologic data with respect to the potential association between breast-feeding and breast cancer risk among various racial and ethnic groups within the United States are substantially more limited.
Studies of migrants suggest that environmental factors are largely responsible for the international variation in breast cancer incidence rates. Patterns among migrants to the United States show that women born in countries with low breast cancer rates, such as China and Japan, experience an increase in rates above those of their country of birth but still below U.S. rates (2). Wu et al. (34) conducted a study among Asian-Americans, both American-born and migrants, to investigate if breast-feeding had a protective effect on breast cancer risk in this population. No statistically significant trend of decreasing breast cancer risk with increasing duration of breast-feeding was observed.
Mayberry et al. (35) conducted a case-control study of African-American and Caucasian women to determine if there were different breast cancer risk profiles between the two races. The multivariate analysis of breast-feeding among parous women of both races indicated that increasing total months of breast-feeding was associated with decreased breast cancer risk among both African-Americans and Caucasians. However, the magnitude of the protective effect was larger among African-American than among Caucasian women, with adjusted ORs of 0.45 and 0.76, respectively, for women who breast-fed for 16 months or longer compared with those who breast-fed for fewer than 4 months.
Similarly, a study of risk factors for breast cancer among Hispanic and non-Hispanic white women found that the protective effect of longer cumulative duration of breast-feeding varied between these two groups (29). Non-Hispanic white women who breast-fed for longer than 12 months had a statistically significant reduced OR of 0.58, while Hispanic women who breast-fed the same length of time had an OR of 0.78 that was not statistically significant.
Menopausal Status
Examination of the pattern of breast cancer risk among parous women
by menopausal status has produced inconsistent results. However, in
most studies (7,8,10-14,17,18,22-26,36), any apparently
protective effect of breast-feeding was stronger among, or confined to,
premenopausal women, despite differences in the classification of
menopausal status. Adjusted ORs for premenopausal parous women who have
ever breast-fed compared with those who never breast-fed ranged from
0.58 to 1.14 (Tables 2, 4
, and 6
). The findings of the United Kingdom
National Case-Control Study (20), as well as a number of
other investigations (11,14,22,36), indicate a statistically
significantly decreasing risk for breast cancer among young women with
increasing duration of breast-feeding or with number of children
breast-fed. If, indeed, there is an inverse association between
breast-feeding and breast cancer that is confined to young women, the
small number of premenopausal women in the prospective study of Kvale
and Heuch (4) may have reduced the statistical power to detect
a modest association.
Few investigations have reported a statistically significant inverse association between breast-feeding and postmenopausal breast cancer. One case-control study in Los Angeles (16) found that postmenopausal women who breast-fed for at least 16 months had a reduced risk of breast cancer (OR = 0.73; 95% CI = 0.52-1.01) relative to postmenopausal women who never breast-fed, suggesting that a protective effect of breast-feeding may persist into the postmenopausal years. However, the collective evidence for an inverse relation between breast-feeding and postmenopausal breast cancer is limited, with numerous studies (5,7,8,10,11,13,14,25,36) reporting no such association. It is possible that postmenopausal women may have more difficulty recalling past breast-feeding habits, thereby attenuating any association with breast cancer risk.
![]() |
BIOLOGIC MECHANISMS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
It has also been suggested that a protective effect of breast-feeding on breast cancer risk may be attributed to the excretion of carcinogenic agents from the breast ductal tissue through breast-feeding (39). For instance, there is some evidence that the level of a potential carcinogen, cholesterol-ß-epoxide, is lower in the breast fluid of women during and up to 2 years after breast-feeding (40). However, it would be expected that these carcinogens would, in turn, affect the child being breast-fed, an association that has not been reported in epidemiologic studies.
Milk from unsuckled breasts has been shown to have a slightly higher pH in comparison to that from suckled breasts, which remains acidic during breast-feeding (41). Studies (39) have shown that epithelial cells in an alkaline environment undergo preneoplastic alterations, such as hyperplasia, cell atypia, and increased mitotic activity at a more frequent rate.
Alternatively, physical changes in the epithelial cells of the mammary ducts, including extended terminal differentiation induced by lactation, may directly affect risk by making the breast tissue more resistant to carcinogenesis (42). The lactational period of the mammary gland is characterized by the presence of lobule type 4, a lobular structure that represents maximal development and differentiation and which is not present among nulliparous women (42).
Finally, the effect of breast-feeding may be attributed to its role in delaying the re-establishment of ovulation (43), although the relation between cumulative number of ovulatory cycles and breast cancer risk remains controversial. Moreover, it has not been shown that breast cancer risk relates more strongly to duration of exclusive breast-feeding (until supplementation) than to duration of total breast-feeding (15), which would be expected if this were the underlying mechanism.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Future research should address the possibility that breast-feeding delays the occurrence of breast cancer among premenopausal women and that the postponed breast cancer cases occur postmenopausally and mask a similarly generated protective effect among postmenopausal women. Moreover, if, in fact, an inverse association does exist between breast-feeding and breast cancer, it may be important to examine the joint effect on breast cancer risk of breast-feeding on the one hand and family history of breast cancer or genetic susceptibility on the other. Finally, it should be investigated whether breast-feeding from smaller breasts, representing smaller mammary gland mass, may be more protective.
Clearly, assessment of the effects of breast-feeding on breast cancer risk is complicated, and most studies have limited data on breast-feeding histories, including reasons for starting or discontinuing breast-feeding and the manner of introduction of supplemental formula. This may be of particular importance when comparing results from populations with different breast-feeding practices. For instance, in non-Western populations in which extended breast-feeding is the norm and there are relatively few women who never breast-feed, a reference group of parous women who have never breast-fed is likely to have different characteristics compared with the same reference group from a population in which breast-feeding is less common (17).
Breast-feeding is a potentially modifiable behavior, and an understanding of its contribution to the etiology of breast cancer is clearly a major research and public health priority. However, breast-feeding may not be a practical intervention for women in the United States and in other Western societies if, in fact, a protective effect of breast-feeding on breast cancer risk is apparent only after prolonged periods of breast-feeding. The choice to breast-feed is primarily determined by socioeconomic considerations and concerns for the health of the child, and only if there were convincing evidence for a strong effect of breast-feeding against breast cancer risk would a public health recommendation of breast-feeding for the benefit of the mother be justified.
![]() |
NOTES |
---|
We thank Johnson Eyadiel for his help with literature research.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1 Lane-Claypon JE. A further report on cancer of the breast with special reference to its associate antecendent conditions. In: Report on public health and medical subjects. No. 32. London (U.K.): HMSO; 1926.
2 Lipworth L. Epidemiology of breast cancer. Eur J Cancer Prev 1995;4:7-30.[Medline]
3 MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, et al. Lactation and cancer of the breast. A summary of an international study.Bull WHO 1970;42:185-94.[Medline]
4 Kvale G, Heuch I. Lactation and cancer risk: is there a relation specific to breast cancer? J Epidemiol Community Health 1987;42:30-7.[Abstract]
5 London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner BA, Corsano K, et al. Lactation and risk of breast cancer in a cohort of US women. Am J Epidemiol 1990;13:17-26.
6 Michels KB, Willett WC, Rosner BA, Manson JE, Hunter DJ, Colditz GA, et al. Prospective assessment of breast-feeding and breast cancer incidence among 89,887 women. Lancet 1996;347:431-6.[Medline]
7 Yoo KY, Tajima K, Kuroishi T, Hirose K, Yoshida M, Miura S, et al. Independent protective effect of lactation against breast cancer: a casecontrol study in Japan. Am J Epidemiol 1992;135:726-33.[Abstract]
8 Katsouyanni K, Lipworth L, Trichopoulou A, Samoli E, Stuver S, Trichopoulos D. A case-control study of lactation and cancer of the breast. Br J Cancer 1996;73:814-8.[Medline]
9 Brinton LA, Hoover R, Fraumeni JF Jr. Reproductive factors in the aetiology of breast cancer. Br J Cancer 1983;47:757-62.[Medline]
10 Siskind V, Schofield F, Rice D, Bain C. Breast cancer and breast-feeding: results from an Australian case-control study. Am J Epidemiol 1989;130:229-36.[Abstract]
11
Newcomb PA, Storer BE, Longnecker MP. Lactation and a
reduced risk of premenopausal breast cancer. N Engl J Med 1994;330:81-7.
12 Romieu I, Hernandez-Avila M, Lazcano E, Lopez L, Romero-Jaime R. Breast cancer and lactation history in Mexican women. Am J Epidemiol 1996;143:543-52.[Abstract]
13 Byers T, Graham S, Rzepka T, Marshall J. Lactation and breast cancer. Evidence for a negative association in premenopausal women. Am J Epidemiol 1985;12:664-74.
14 Yang CP, Weiss NS, Band PR, Gallagher RP, White E, Daling JR. History of lactation and breast cancer risk. Am J Epidemiol 1993;138:1050-6.[Abstract]
15 Brinton LA, Potischman NA, Swanson CA, Schoenberg JB, Coates RJ, Gammon MD, et al. Breast-feeding and breast cancer risk. Cancer Causes Control 1995;6:199-08.[Medline]
16 Enger SM, Ross RK, Paganini-Hill A, Bernstein L. Breast-feeding experience and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:365-9.[Abstract]
17 Freudenheim JL, Marshall JR, Vena JE, Moysich KB, Muti P, Laughlin R, et al. Lactation history and breast cancer risk. Am J Epidemiol 1997;146:932-8.[Abstract]
18 Stuver SO, Hsieh CC, Bertone E, Trichopoulos D. The association between lactation and breast cancer in an international case-control study: a re-analysis by menopausal status. Int J Cancer 1997;71:166-9.[Medline]
19 Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, et al. Risk factors for breast cancer in women in Northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst 1982;68:211-7.[Medline]
20 United Kingdom National Case-Control Study Group. Breast feeding and risk of breast cancer in young women. BMJ 1993;307:17-20.[Medline]
21 Negri E, Braga C, La Vecchia C, Levi F, Talamini R, Franceschi S. Lactation and the risk of breast cancer in an Italian population. Int J Cancer 1996;67:161-4.[Medline]
22 Enger SM, Ross RK, Henderson B, Bernstein L. Breast-feeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997;76:118-23.[Medline]
23 Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, Ory HW, et al. The independent associations of parity, age at first full term pregnancy, and duration of breast-feeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 1989;42:963-73.[Medline]
24 Adami HO, Bergstrom R, Lunk E, Meirik O. Absence of an association between reproductive variables and the risk of breast cancer in young women in Sweden and Norway. Br J Cancer 1990;62:122-6.[Medline]
25 Thomas DB, Noonan EA, WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and prolonged lactation. Int J Epidemiol 1993;2:619-26.
26 Tao SC, Yu MC, Ross RK, Xiu KW. Risk factors for breast cancer in Chinese women of Beijing. Int J Cancer 1988;4:495-8.
27 Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 1988;48:1949-53.[Abstract]
28 Wang QS, Ross RK, Yu MC, Ning JP, Henderson BE, Kimm HT. A case-control study of breast cancer in Tianjin, China. Cancer Epidemiol Biomarkers Prev 1992;1:435-9.[Abstract]
29 Gilliland FD, Hunt WC, Baumgartner KB, Crumley D, Nicholson CS, Fetherolf J, et al. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women's Health Study. Am J Epidemiol 1998;148:683-92.[Abstract]
30 Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, et al. Age at any birth and breast cancer risk. Int J Cancer 1983;31:701-4.[Medline]
31 Lippman MC, Allegra JC. Current concepts in cancer. Receptors in breast cancer. N Engl J Med 1978;299:930-3.[Medline]
32 Hildreth NG, Kelsey JL, Eisenfeld AJ, LiVolsi VA, Holford TR, Fischer DB. Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst 1983;70:1027-31.[Medline]
33 McTiernan A, Thomas DB, Johnson LK, Roseman D. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst 1986;77:849-54.[Medline]
34 Wu AH, Ziegler RG, Pike MC, Nomura AM, West DW, Kolonel LN, et al. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 1996;73:680-6.[Medline]
35 Mayberry RM, Stoddard-Wright C. Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol1992 ;136:1445-56.[Abstract]
36 McTiernan A, Thomas DB. Evidence for a protective effect of lactation on risk of breast cancer in young women. Results from a case-control study. Am J Epidemiol 1986;124:353-8.[Abstract]
37 Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-34.[Medline]
38 Petrakis NL, Wrensch MR, Ernster VL, Miike R, Murai J, Simberg N, et al. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 1987;40:587-91.[Medline]
39 Murrell TG. Epidemiological and biochemical support for a theory on the cause and prevention of breast cancer. Med Hypotheses 1991;36:389-96.[Medline]
40 Gruenke LD, Wrensch MR, Petrakis NL, Miike R, Ernster VL, Craig JC. Breast fluid cholesterol and cholesterol epoxides: relationship to breast cancer risk factors and other characteristics. Cancer Res 1987;47:5483-7.[Abstract]
41 Kennedy KI. Effects of breast-feeding on women's health. Int J Gynaecol Obstet 1994;47 Suppl:S11-S21; discussion S20-1.[Medline]
42 Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994;3:353-64.[Abstract]
43 Henderson BE, Pike MC, Casagrande JT. Breast cancer and the oestrogen window hypothesis. Lancet 1981;2:363-4.[Medline]
Manuscript received March 28, 1999; revised November 29, 1999; accepted December 7, 1999.
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
||||
|
Oxford University Press Privacy Policy and Legal Statement |